Literature DB >> 1326000

The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.

K S Kim1, H Itabashi, P Gemski, J Sadoff, R L Warren, A S Cross.   

Abstract

Although Escherichia coli strains possessing the K1 capsule are predominant among isolates from neonatal E. coli meningitis and most of these K1 isolates are associated with a limited number of 0 lipopolysaccharide (LPS) types, the basis of this association of K1 and certain 0 antigens with neonatal E. coli meningitis is not clear. The present study examined in experimental E. coli bacteremia and meningitis in newborn and adult rats whether or not the K1 capsule and/or O-LPS antigen are critical determinants in the development of meningitis. Rats received subcutaneously at K1 E. coli strain (018+K1+) or mutants lacking either the K1 capsule (018+K1-) or 0 side-chain (018-K1+). 12-24 h later, blood and cerebrospinal fluid (CSF) specimens were obtained for quantitative cultures. The isolation of E. coli from CSF was observed in both newborn and adult rats infected with K1+ strains regardless of LPS phenotype (018+ or 18-) who also developed a high degree of bacteremia (e.g., greater than 10(4) CFU/ml of blood). In contrast, none of the newborn and adult rats infected with 018+K1- and developing bacteremia of greater than 10(4) were found to have positive CSF cultures. These findings indicate that the presence of the K1 capsule and a high degree of bacteremia are key determinants in the development of E. coli meningitis, suggesting that there may be specific binding sites present in the brain which have an affinity for the K1 capsule and thus may be responsible for the entry of K1-encapsulated E. coli into the meninges.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326000      PMCID: PMC329944          DOI: 10.1172/JCI115965

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Studies on the pathogenesis of meningitis. II. Development of meningitis during pneumococcal bacteremia.

Authors:  R G PETERSDORF; D R SWARNER; M GARCIA
Journal:  J Clin Invest       Date:  1962-02       Impact factor: 14.808

2.  Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.

Authors:  K S Kim; J H Kang; A S Cross; B Kaufman; W Zollinger; J Sadoff
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

Review 3.  Current topics in host defenses of the newborn.

Authors:  M E Miller
Journal:  Adv Pediatr       Date:  1978

4.  Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity.

Authors:  P Stevens; S N Huang; W D Welch; L S Young
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

Review 5.  Serology, chemistry, and genetics of O and K antigens of Escherichia coli.

Authors:  I Orskov; F Orskov; B Jann; K Jann
Journal:  Bacteriol Rev       Date:  1977-09

Review 6.  Bacterial meningitis in the newborn infant.

Authors:  R D Feigin
Journal:  Clin Perinatol       Date:  1977-03       Impact factor: 3.430

7.  Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.

Authors:  K S Kim; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

8.  Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli.

Authors:  A S Cross; K S Kim; D C Wright; J C Sadoff; P Gemski
Journal:  J Infect Dis       Date:  1986-09       Impact factor: 5.226

9.  Efficacy of human immunoglobulin and penicillin G in treatment of experimental group B streptococcal infection.

Authors:  K S Kim
Journal:  Pediatr Res       Date:  1987-03       Impact factor: 3.756

10.  Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.

Authors:  K S Kim
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

View more
  87 in total

1.  Escherichia coli K1 aslA contributes to invasion of brain microvascular endothelial cells in vitro and in vivo.

Authors:  J A Hoffman; J L Badger; Y Zhang; S H Huang; K S Kim
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

Review 2.  Escherichia coli translocation at the blood-brain barrier.

Authors:  K S Kim
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Identification and characterization of an Escherichia coli invasion gene locus, ibeB, required for penetration of brain microvascular endothelial cells.

Authors:  S H Huang; Y H Chen; Q Fu; M Stins; Y Wang; C Wass; K S Kim
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Entry and intracellular replication of Escherichia coli K1 in macrophages require expression of outer membrane protein A.

Authors:  Sunil K Sukumaran; Hiroyuki Shimada; Nemani V Prasadarao
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

5.  Detection of the Escherichia coli group 2 polysaccharide capsule synthesis Gene kpsM by a rapid and specific PCR-based assay.

Authors:  James R Johnson; Timothy T O'Bryan
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

6.  Prevention of Escherichia coli K1 penetration of the blood-brain barrier by counteracting the host cell receptor and signaling molecule involved in E. coli invasion of human brain microvascular endothelial cells.

Authors:  Longkun Zhu; Donna Pearce; Kwang Sik Kim
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

7.  Ability of Escherichia coli isolates that cause meningitis in newborns to invade epithelial and endothelial cells.

Authors:  C Meier; T A Oelschlaeger; H Merkert; T K Korhonen; J Hacker
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

8.  Paneth cells and antibacterial host defense in neonatal small intestine.

Authors:  Michael P Sherman; Stephen H Bennett; Freda F Y Hwang; Jan Sherman; Charles L Bevins
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

9.  TraJ-dependent Escherichia coli K1 interactions with professional phagocytes are important for early systemic dissemination of infection in the neonatal rat.

Authors:  Val T Hill; Stacy M Townsend; Robyn S Arias; Jasmine M Jenabi; Ignacio Gomez-Gonzalez; Hiroyuki Shimada; Julie L Badger
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Escherichia coli invasion of brain microvascular endothelial cells in vitro and in vivo: molecular cloning and characterization of invasion gene ibe10.

Authors:  S H Huang; C Wass; Q Fu; N V Prasadarao; M Stins; K S Kim
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.